Identification of potential crucial genes associated with carcinogenesis of clear cell renal cell carcinoma
暂无分享,去创建一个
Mingbo Zhao | Xin Ma | Xu Zhang | Wenjun Ni | Xin Ma | Xu Zhang | L. Xing | Erlin Song | Wenting Song | Minghua Ren | Li Xing | Yongxiang Li | Mancheng Gong | Ruihua An | Yongxiang Li | W. Ni | Er-lin Song | Ruihua An | Minghua Ren | Mancheng Gong | Wenting Song | Mingbo Zhao
[1] P. Liu,et al. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population. , 2012, Genetic testing and molecular biomarkers.
[2] P. Stephens,et al. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. , 2016, European urology.
[3] J. Cheville,et al. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] F. Waldman,et al. EGF‐r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization , 1998, The Journal of pathology.
[5] Hong-zhao Li,et al. Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques. , 2016, European urology.
[6] M. Duffy. Use of Biomarkers in Screening for Cancer , 2010, EJIFCC.
[7] R. Montironi,et al. The prospect of precision therapy for renal cell carcinoma. , 2016, Cancer treatment reviews.
[8] N. Grishin,et al. BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.
[9] D. Radisky,et al. Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. , 2014, Cancer research.
[10] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[11] A. Steiner,et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. , 2013, The Journal of investigative dermatology.
[12] Nicholas J Vogelzang,et al. Novel Therapies for Metastatic Renal Cell Carcinoma: Efforts to Expand beyond the VEGF/mTOR Signaling Paradigm , 2012, Molecular Cancer Therapeutics.
[13] X. Chen,et al. Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells , 2016, Oncology reports.
[14] Klaus Jung,et al. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p , 2016, PloS one.
[15] E. Diamandis,et al. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies , 2008, Nature Clinical Practice Oncology.
[16] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[17] Kumardeep Chaudhary,et al. Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer , 2017, Scientific Reports.
[18] S. Perner,et al. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma , 2015, Clinical Epigenetics.
[19] J. Stetefeld,et al. Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells. , 2012, Neoplasia.
[20] P. Zhang,et al. Retroperitoneal Laparoscopic Partial Nephrectomy for Tumors Larger than 7 cm in Renal Cell Carcinoma: Initial Experience of Single-Institution. , 2017, Journal of laparoendoscopic & advanced surgical techniques. Part A.
[21] Xiaolong Li,et al. The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma , 2017, OncoTargets and therapy.
[22] Lindsay A. Williams,et al. MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma , 2017, Nature Communications.
[23] E. Stefan,et al. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer. , 2017, Current topics in microbiology and immunology.
[24] J. Gautier,et al. Cdc45 is a critical effector of myc-dependent DNA replication stress. , 2013, Cell reports.
[25] Sai-Wen Tang,et al. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. , 2009, Cancer letters.
[26] Han Yong Choi,et al. The epidemiology of renal cell carcinoma. , 2011, European urology.
[27] S. Dadras,et al. An unexpected role for EGF in lymphangiogenesis-mediated melanoma metastasis to sentinel lymph nodes. , 2013, The Journal of investigative dermatology.
[28] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[29] Rafael A. Irizarry,et al. A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..
[30] Roy S Herbst,et al. Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.
[31] Bruno Amati,et al. Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.
[32] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[33] Lorenzo Marconi,et al. EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.
[34] Houjie Liang,et al. Distinct Role of CD86 Polymorphisms (rs1129055, rs17281995) in Risk of Cancer: Evidence from a Meta-Analysis , 2014, PloS one.
[35] Jianmin Wu,et al. KOBAS server: a web-based platform for automated annotation and pathway identification , 2006, Nucleic Acids Res..
[36] S. Culine,et al. Kidney Cancer Pathology in the New Context of Targeted Therapy , 2011, Pathobiology.
[37] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[38] K. Mimori,et al. A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer. , 2014, Oncology reports.
[39] L. Larsson,et al. MYC Modulation around the CDK2/p27/SKP2 Axis , 2017, Genes.
[40] V. Yassaee,et al. Mutation spectra of the ITGB2 gene in Iranian families with leukocyte adhesion deficiency type 1. , 2016, Human immunology.
[41] Gary D Bader,et al. Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.
[42] H. Verheul,et al. Novel drugs that target the metabolic reprogramming in renal cell cancer , 2016, Cancer & Metabolism.
[43] V. Margulis,et al. Integrin signaling potentiates transforming growth factor‐beta 1 (TGF‐&bgr;1) dependent down‐regulation of E‐Cadherin expression – Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma , 2017, Experimental cell research.
[44] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[45] W. Dippold,et al. Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] Wancai Yang,et al. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis , 2017, International journal of molecular sciences.
[47] W. Hahn,et al. Analysis of tumor- and stroma-supplied proteolytic networks reveals a brain metastasis-promoting role for cathepsin S , 2014, Nature Cell Biology.
[48] Alec Smith,et al. Critical Role , 2019, They Create Worlds.
[49] L. Gossage,et al. Alterations in VHL as potential biomarkers in renal-cell carcinoma , 2010, Nature Reviews Clinical Oncology.